In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus

References

• AOYAMA, T., YAMANO, S., GUZELIAN, P. S., GELBOINT, H. V. and GONZALEZ, F. J., 1990, Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proceedings of the National Academy of Sciences, USA, 87, 4790–4793.
   PubMed Web of Science ®Google Scholar
• APONSO, L., MIRANDA, C. L., STEVENS, J. F., DEINZER, M. L. and BUHLER, D. R., 1998, Induction of quinone reductase by flavonoids from hops (Humulus lupulus) in cultured mouse hepatoma (Hepa lel c7) cells. Toxicological Sciences, 42, 185.
   Google Scholar
• ARIMOTO -KOBAYASHI, S., SUGIYAMA C., HARADA, N., TAKEUCHI, M., TAKEMURA, M. and HAYATSU, H., 1999, Inhibitory effects of beer and other alcoholic beverages on mutagenesis and DNA adduct formation induced by several carcinogens. Journal of Agricultural and Food Chemistry, 47, 221–230.
   Google Scholar
• BOHM, B. A., 1993, The minor flavonoids. In J. B. Harborne (ed.), The Flavonoids (New York: Chapman & Hall), pp. 387–440.
   Google Scholar
• CHANG, T. K. H., GONZALEZ, F. J. and WAXMAN, D. J., 1994, Evaluation of triacetyloleandomycin, a-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human P450. Archives of Biochemistry and Biophysics, 311,437–442.
   Google Scholar
• CODE, E. L., CRESPI, C. L., PENMAN, B. W., GONZALEZ, F. J., CHANG, T. K. and WAXMAN, D. J., 1997, Human cytochrome P4502 B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metabolism and Disposition, 25, 985–993.
   PubMed Web of Science ®Google Scholar
• EDENHARDER, R., RAUSCHER, R. and PLATT, K. L., 1997, The inhibition by flavonoids of 2-amino -3-methylimidazo[4,5 -Aquinoline metabolic activation to a mutagen: a structure—activity relation-ship study. Mutation Research, 379, 21–32.
   PubMed Web of Science ®Google Scholar
• GALLAGHER, E. P., KUNZE, K. L., STAPLETON, P. L. and EATON, D. L., 1996, The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicology and Applied Pharmacology, 141,595–606.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, F. J. and GELBOIN, H. V., 1994, Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metabolism Reviews, 26, 165–183.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1989, Analysis and characterization of enzymes. In A. Wallace Hayes (ed.), Principles and Methods of Toxicology, 2nd edn, pp. 777–813.
   Google Scholar
• GUENGERICH, F. P., 1995, Human cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn (New York: Plenum), pp. 473–535.
   Google Scholar
• GUENGERICH, F. P. and KIM, D. H., 1990, In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis, 11, 2275–2279.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMERS, P., Wow, T. and WAXMAN, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry, 261, 5051–5060.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4,391–407.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., SHIMADA, T., RANEY, K. D., YUN, C. H., MEYER, D. J., KETTERER, B., HARRIS, T. M., GROOPMAN, J. D. and KADLUBAR, F. F., 1992, Elucidation of the catalytic specificities of human cytochromes P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology. Environmental Health Perspectives, 98, 75–80.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., SHEVIADA, T., YUN, C. H., YAMAZAKI, H., RANEY, K. D., TRIER, R., COLES, B. and HARRIS, T. M., 1994, Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2,2A6,2E1, and 3A4 enzymes. Environmental Health Perspectives, 102 (suppl. 9), 49–53.
   PubMed Web of Science ®Google Scholar
• HENDERSON, M. C., MIRANDA, C. L., STEVENS, J. F., DEINZER, M. L. and BUHLER, D. R., 1998, In vitro inhibition of carcinogen metabolism by flavonoids from hops (Humulus lupulus) in various species. Toxicological Science, 42, 185.
   Google Scholar
• Liu, G., GELBOIN, H. V. and MYERS, M. J., 1991, Role of cytochrome P450 1A2 in acetanilide 4-hydroxylation as determined with cDNA expression and monoclonal antibodies. Archives of Biochemistry and Biophysics, 284, 400–406.
   PubMed Web of Science ®Google Scholar
• MANSON, M. M., BALL, H. W. L., BARRETT, M. C., CLARK, H. L., JUDAH, D. J., WILLIAMSON, G. and NEAL, G. E. 1997, Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogenesis, 18, 1729–1738.
   Google Scholar
• MIDDLETON, E. JR and KANDASWAMI, C., 1994, The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In J. B. Harborne (ed.), The Flavonoids (New York: Chapman & Hall), pp. 619–652.
   Google Scholar
• MIRANDA, C. L. STEVENS, J. F., HELMRICH, A., HENDERSON, M. C., RODRIGUEZ, R. J., YANG, Y.-H., DEINZER, M. L., BARNES, D. W. and BUHLER, D. R., 1999, Anti-proliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food and Chemical Toxicology, 37, 271–285.
   Google Scholar
• MUKHTAR, H. and AHMAD, N., 1999, Cancer chemoprevention: future holds in multiple agents. Toxicology and Applied Pharmacology, 158, 207–210.
   PubMed Web of Science ®Google Scholar
• NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• OBERMEIER, M. T., WHITE, R. E. and YANG, C. S., 1995, Effects of bioflavonoids on hepatic P450 activities. Xenobiotica, 25, 575–584.
   PubMed Web of Science ®Google Scholar
• PENMAN, B. W., CHEN, L., GELBOIN, H. V., GONZALEZ, F. J. and CRESPI, C. L., 1994, Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens. Carcinogenesis, 15, 1931–1937.
   PubMed Web of Science ®Google Scholar
• PETER, R., BOCKER, R. G., BEAUNE, P. H., IwAsmu, M., GUENGERICH, F. P. and YANG, C. S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 11E1. Chemical Research in Toxicology, 3, 566–573.
   PubMed Web of Science ®Google Scholar
• PEZZUTO, J. M., 1997, Plant-derived anticancer agents. Biochemical Pharmacology, 53, 121–133.
   PubMed Web of Science ®Google Scholar
• POHL, R. J. and Fours, J. R., 1980, A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Annals of Biochemistry, 107, 150–155.
   Web of Science ®Google Scholar
• SHIMADA, T., HAYES, C. L., YAMAZAKI, H., AMEN, S., HECHT, S. S., GUENGERICH, F. P. and SUTTER, T. R., 1996, Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Research, 56, 2979–2984.
   PubMed Web of Science ®Google Scholar
• Suou, M., KORZEKWA, K. R., CRESPI, C. L., GONZALEZ, F. J. and GELBOIN, H. V., 1994, The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of the benzo[a]pyrene and benz o [a] pyrene trans-7,8 -dihydrodiol. Molecular Carcinogenesis, 10, 159–168.
   PubMed Web of Science ®Google Scholar
• SHOU, M., KORZEKWA, K. R., KRAUSZ, K. W., BUTERS J. T., GROGAN, J., GOLDFARB, I., HARDWICK, J. P., GONZALEZ, F. J. and GELBOIN, H. V., 1996b, Specificity of cDNA-expressed human and rodent cytochrome P450 in the oxidative metabolism of the potent carcinogen 7,12-dimethybenz[a]anthracene. Molecular Carcinogenesis, 17, 241–249.
   Google Scholar
• Suou, M., KRAUSZ, K. W., GONZALEZ, F. J. and GELBOIN, H. V., 1996a, Metabolic activation of the potent carcinogen dibenzo[a,l]pyrene by human recombinant cytochromes P450, lung and liver microsomes. Carcinogenesis, 17, 2429–2433.
   PubMed Web of Science ®Google Scholar
• Suou, M., KRAUSZ, K. W., GONZALEZ, F. J. and GELBOIN, H. V., 1996c, Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450. Archives of Biochemistry and Biophysics, 328, 201–207.
   PubMed Web of Science ®Google Scholar
• SIEss, M.-H., LECLERC, J., CANIVENC -LAVIER, M.-C., RAT, P. and SUSCHETET, M., 1995, Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicology and Applied Pharmacology, 130, 73–78.
   Google Scholar
• STEVENS, J. F., IvANcic, M., Hsu, V. L. and DEINZER, M. L., 1997, Prenylflavonoids from Humulus lupulus. Phytochemistry, 44, 1575–1585.
   Web of Science ®Google Scholar
• STEVENS, J. F., MIRANDA, C. L., BUHLER, D. R. and DEINZER, M. L, 1998, Chemistry and biology of hop flavonoids. Journal of the American Society of Brewing Chemistry, 56, 136–145.
   Web of Science ®Google Scholar
• STEVENS, J. F., TAYLOR, A. W. and DEINZER, M. L., 1999a, Quantitative analysis of xanthohumol and related flavonoids in hops and beer by liquid chromatography tandem mass spectrometry. journal of Chromatography, A832, 97–107.
   PubMed Web of Science ®Google Scholar
• STEVENS, J. F. TAYLOR, A. W., CLAWSON J. E. and DEINZER, M. L., 1999b, Fate of xanthohumol and related prenylflavonoids from hops to beer. Journal of Agricultural and Food Chemistry, 47, 2421–2428.
   Google Scholar
• STRESSER, D. M., WILLIAMS, D. E., MCLELLAN, L. I., HARRIS, T. M. and BAILEY, G. S., 1994, Indole 3-carbinol induces a rat liver glutathione transferaw subunit (yc2) with high activity toward aflatoxin B1-exo-epoxide. Drug Metabolism and Disposition, 22, 392–399.
   PubMed Web of Science ®Google Scholar
• TASSANEEYAKUL W., BIRKETT, D. J., VERONESE, M. E., MuMANus, M. E., TUKEY, R. H., QUATTROCHI L. C., GELBOIN, H. V. and MINERS, J. O., 1993, Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Journal of Pharmacology and Experimental Therapeutics, 265, 401–407.
   PubMed Web of Science ®Google Scholar
• TSYRLOV, I. B., MIKHAILENKO, V. M. and GELBOIN, H. V., 1994, Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochimica et Biophysica Acta, 1205, 325–335.
   PubMed Web of Science ®Google Scholar
• WATTENBURG, L. W., 1983, Inhibition of neoplasia by minor dietary constituents. Cancer Research, 26, 1520–1526.
   Google Scholar
• YILMAZER M., STEVENS, J. F., DEINZER, M. L. and BUHLER, D. R., 1999, In vitro biotransformation of xanthohumol by rat liver microsomes. Toxicological Sciences, 48, 223.
   Google Scholar
• ZHAO, K., SURRAY, S., DAVIES, D. S., BOOMS, A. R. and GOODERSHAM, N. J., 1994, Metabolism of the food derived mutagen and carcinogen 2-amino-1 -methyl 6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes. Carcinogenesis, 15, 1285–1288.
   PubMed Web of Science ®Google Scholar